National Lipid Association Scientific Sessions

Healio brings you the highlights from the National Lipid Association Scientific Sessions. Refer back to this page often for the latest news from NLA, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News

LDL lowering more robust in men vs. women in concomitant PCSK9 inhibitor, statin therapy

May 20, 2017
PHILADELPHIA — In a small cohort of patients taking PSCK9 inhibitors, men had a lower reduction in LDL than women among those also on statin
Meeting News

PCSK9 inhibitor studies show benefit for patients with high LDL

May 20, 2017
PHILADELPHIA — Numerous studies on PCSK9 inhibitors have been completed that establish their efficacy and safety in patients with high LDL
Meeting News

Performance of CETP inhibitors vexing

May 20, 2017
PHILADELPHIA — While cholesterol ester transfer protein inhibitors raise HDL and some lower LDL, they have so far not shown any impact on CV
Meeting News

New therapeutic approaches for familial chylomicronemia syndrome in development

May 20, 2017
PHILADELPHIA — A number of new therapeutic approaches may change the treatment approach for patients with familial chylomicronemia syndrome, a
Meeting News

Future holds promise to address unmet needs in lipid disorders causing CV risk

May 19, 2017
PHILADELPHIA — Despite success with therapies that lower LDL, other lipid disorders confer risk for CVD that are not well-controlled, but…
Meeting News

Damaging mutations in ABCA1, APOA1 linked to atherosclerosis

May 19, 2017
PHILADELPHIA — In patients with low HDL, a damaging mutation in ABCA1 or APOA1 is associated with an increased risk for subclinical…
Meeting News

Most youth with FH not sufficiently treated for hyperlipidemia

May 19, 2017
PHILADELPHIA — Opportunities exist to optimize the treatment of youth with familial hypercholesterolemia to reduce their risk for CV diseases…
Meeting News

Evidence varies for nonstatin lipid-lowering therapies

May 19, 2017
PHILADELPHIA — The current evidence for PCSK9 inhibitors reducing CV events in high-risk patients is strong, but other questions surrounding…
Meeting NewsVideo

VIDEO: Expert discusses role of genetics in early-age MI

May 19, 2017
PHILADELPHIA — In this Cardiology Today video exclusive, Sekar Kathiresan, MD, cardiologist at Massachusetts General Hospital and human…
Meeting News

For lipid-lowering therapies, outcomes data impact guidelines, clinical practice

May 18, 2017
PHILADELPHIA — Evidence for lipid-lowering therapies has evolved over the years, but what remains consistent is the impact of new evidence on